61,390 Shares in Proto Labs, Inc. $PRLB Bought by Notis McConarty Edward

Notis McConarty Edward acquired a new stake in Proto Labs, Inc. (NYSE:PRLBFree Report) during the 2nd quarter, Holdings Channel reports. The fund acquired 61,390 shares of the industrial products company’s stock, valued at approximately $5,571,000. Proto Labs makes up approximately 2.4% of Notis McConarty Edward’s portfolio, making the stock its 16th biggest holding.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Group One Trading LLC bought a new position in Proto Labs in the fourth quarter valued at about $25,000. NewEdge Advisors LLC lifted its holdings in shares of Proto Labs by 7,380.0% in the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after acquiring an additional 738 shares during the last quarter. NBC Securities Inc. bought a new position in shares of Proto Labs in the fourth quarter worth about $46,000. USA Financial Formulas acquired a new stake in shares of Proto Labs in the 1st quarter valued at approximately $52,000. Finally, Modus Advisors LLC acquired a new stake in shares of Proto Labs in the 4th quarter valued at approximately $57,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Trading Down 3.3%

Shares of PRLB stock opened at $82.11 on Thursday. The business’s 50-day moving average price is $80.53 and its 200-day moving average price is $69.94. Proto Labs, Inc. has a 12 month low of $45.10 and a 12 month high of $93.00. The firm has a market capitalization of $1.96 billion, a price-to-earnings ratio of 65.69 and a beta of 1.40.

Proto Labs (NYSE:PRLBGet Free Report) last released its quarterly earnings data on Friday, July 31st. The industrial products company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.07. The company had revenue of $149.34 million during the quarter, compared to the consensus estimate of $144.53 million. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The firm’s revenue was up 10.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 earnings per share. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. On average, sell-side analysts predict that Proto Labs, Inc. will post 1.46 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total value of $154,560.00. Following the completion of the transaction, the director directly owned 32,505 shares in the company, valued at approximately $2,511,986.40. This represents a 5.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on PRLB shares. Weiss Ratings cut shares of Proto Labs from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday. Needham & Company LLC upgraded shares of Proto Labs from a “hold” rating to a “buy” rating and set a $87.00 target price on the stock in a research report on Monday, August 3rd. Benchmark boosted their target price on shares of Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Wall Street Zen downgraded shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 18th. Finally, Zacks Research upgraded shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 6th. One analyst has rated the stock with a Strong Buy rating and three have assigned a Buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $89.00.

Read Our Latest Stock Analysis on PRLB

Proto Labs Company Profile

(Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Read More

Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLBFree Report).

Institutional Ownership by Quarter for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.